DK1027365T3 - Antitumor-uridinanaloger - Google Patents

Antitumor-uridinanaloger

Info

Publication number: DK1027365T3
Authority: DK; Denmark
Prior art keywords: substituted; sugar; alkoxy; alkyl; unsubstituted
Prior art date: 1997-10-30

Application number

DK98958451T

Other languages

English (en)

Inventor

Raymond W Klecker

Lawrence Anderson

Aspandiar G Katki

Jerry M Collins

Original Assignee

Us Gov Health & Human Serv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-30

Filing date

1998-10-30

Publication date

2005-05-30

1998-10-30 Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv

2005-05-30 Application granted granted Critical

2005-05-30 Publication of DK1027365T3 publication Critical patent/DK1027365T3/da

Links

DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 title 1
230000000259 anti-tumor effect Effects 0.000 title 1
125000003545 alkoxy group Chemical group 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 3
229910052736 halogen Inorganic materials 0.000 abstract 3
150000002367 halogens Chemical class 0.000 abstract 3
229910019142 PO4 Inorganic materials 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
239000010452 phosphate Substances 0.000 abstract 2
229910003204 NH2 Inorganic materials 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
108010022394 Threonine synthase Proteins 0.000 abstract 1
102000006601 Thymidine Kinase Human genes 0.000 abstract 1
108020004440 Thymidine kinase Proteins 0.000 abstract 1
102000005497 Thymidylate Synthase Human genes 0.000 abstract 1
125000002015 acyclic group Chemical group 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
229940127073 nucleoside analogue Drugs 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
125000005017 substituted alkenyl group Chemical group 0.000 abstract 1
125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
125000000547 substituted alkyl group Chemical group 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
231100000331 toxic Toxicity 0.000 abstract 1
230000002588 toxic effect Effects 0.000 abstract 1
-1 uridine analogue compounds Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Nuclear Medicine (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK98958451T 1997-10-30 1998-10-30 Antitumor-uridinanaloger DK1027365T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6358797P	1997-10-30	1997-10-30
PCT/US1998/023109 WO1999023104A2 (en)	1997-10-30	1998-10-30	Antitumour uridine analogues

Publications (1)

Publication Number	Publication Date
DK1027365T3 true DK1027365T3 (da)	2005-05-30

Family

ID=22050193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98958451T DK1027365T3 (da)	1997-10-30	1998-10-30	Antitumor-uridinanaloger

Country Status (9)

Country	Link
EP (1)	EP1027365B1 (da)
JP (2)	JP2001522034A (da)
AT (1)	ATE287414T1 (da)
AU (1)	AU758426B2 (da)
CA (1)	CA2307002C (da)
DE (1)	DE69828702T2 (da)
DK (1)	DK1027365T3 (da)
ES (1)	ES2236962T3 (da)
WO (1)	WO1999023104A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE413881T1 (de)	1997-08-08	2008-11-15	Celmed Oncology Usa Inc	Verfahren und zubereitungen um resistenz gegen biologische oder chemische therapien zu überwinden
US7462605B2 (en)	1998-01-23	2008-12-09	Celmed Oncology (Usa), Inc.	Phosphoramidate compounds and methods of use
ES2172303T3 (es)	1998-01-23	2002-09-16	Newbiotics Inc	Agentes terapeuticos obtenidos por catalisis enzimatica.
HK1053126A1 (zh) *	1999-07-22	2003-10-10	新生物生物公司	酶催化的治疗活化
US6683061B1 (en)	1999-07-22	2004-01-27	Newbiotics, Inc.	Enzyme catalyzed therapeutic activation
IL147749A0 (en)	1999-07-22	2002-08-14	Newbiotics Inc	Methods for treating therapy-resistant tumors
MY164523A (en)	2000-05-23	2017-12-29	Univ Degli Studi Cagliari	Methods and compositions for treating hepatitis c virus
PL359169A1 (en)	2000-05-26	2004-08-23	Idenix (Cayman) Limited	Methods and compositions for treating flaviviruses and pestiviruses
EP1331479A4 (en) *	2000-10-06	2005-01-12	Inst Of Whole Body Metabolism	QUANTIFIED TWO-DIMENSIONAL IMAGING METHOD FOR DISTINGUISHING AND QUANTIFYING TISSUE OR SIMILAR EXCESS
WO2002056832A2 (en)	2001-01-19	2002-07-25	Newbiotics, Inc.	Methods to treat autoimmune and inflammatory conditions
GB0115927D0 (en) *	2001-06-29	2001-08-22	Nycomed Amersham Plc	Solid-phase nucleophilic fluorination
AU2003253058A1 (en) *	2002-05-31	2003-12-19	Commissariat A L'energie Atomique	Method of screening groups of radioactive molecules and applications thereof
CN101172993A (zh)	2002-06-28	2008-05-07	埃迪尼克斯(开曼)有限公司	用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
KR20050035194A (ko)	2002-06-28	2005-04-15	이데닉스 (케이만) 리미티드	플라비비리다에 감염 치료용 2'-ｃ-메틸-3'-ｏ-ｌ-발린에스테르 리보푸라노실 사이티딘
AU2003298658A1 (en)	2002-11-15	2004-06-15	Idenix (Cayman) Limited	2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en)	2002-12-12	2009-10-06	Idenix Pharmaceuticals, Inc.	Process for the production of 2-C-methyl-D-ribonolactone
RU2358979C2 (ru)	2003-05-30	2009-06-20	Фармассет, Инк.	Модифицированные фторированные аналоги нуклеозида
EP2348131A1 (en) *	2010-01-22	2011-07-27	Institut Curie	Low levels of cytidine deaminase as a marker for genetic predisposition to develop cancer
JP2014062054A (ja) *	2012-09-20	2014-04-10	Gyoseiin Genshino Iinkai Kakuno Kenkyusho	よう素−１２３標記チミン類似物［１２３Ｉ］−ＩａｒａＵのプローブ

1998
- 1998-10-30 CA CA002307002A patent/CA2307002C/en not_active Expired - Fee Related
- 1998-10-30 AU AU14495/99A patent/AU758426B2/en not_active Ceased
- 1998-10-30 DK DK98958451T patent/DK1027365T3/da active
- 1998-10-30 DE DE69828702T patent/DE69828702T2/de not_active Expired - Lifetime
- 1998-10-30 JP JP2000518974A patent/JP2001522034A/ja active Pending
- 1998-10-30 EP EP98958451A patent/EP1027365B1/en not_active Expired - Lifetime
- 1998-10-30 ES ES98958451T patent/ES2236962T3/es not_active Expired - Lifetime
- 1998-10-30 AT AT98958451T patent/ATE287414T1/de active
- 1998-10-30 WO PCT/US1998/023109 patent/WO1999023104A2/en not_active Ceased
2009
- 2009-02-19 JP JP2009037204A patent/JP2009108108A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
ATE287414T1 (de)	2005-02-15
EP1027365A2 (en)	2000-08-16
WO1999023104A2 (en)	1999-05-14
AU1449599A (en)	1999-05-24
EP1027365B1 (en)	2005-01-19
DE69828702T2 (de)	2006-05-11
DE69828702D1 (de)	2005-02-24
JP2009108108A (ja)	2009-05-21
AU758426B2 (en)	2003-03-20
ES2236962T3 (es)	2005-07-16
WO1999023104A3 (en)	2000-02-10
CA2307002A1 (en)	1999-05-14
JP2001522034A (ja)	2001-11-13
CA2307002C (en)	2008-07-29

Similar Documents

Publication	Publication Date	Title
ATE287414T1 (de)	2005-02-15	Antitumorale uridinderivate
Meier	2002	cycloSal-pronucleotides-design of chemical trojan horses
Frieden et al.	1980	Adenosine deaminase and adenylate deaminase: comparative kinetic studies with transition state and ground state analog inhibitors
Marquez et al.	1998	HIV-1 reverse transcriptase can discriminate between two conformationally locked carbocyclic AZT triphosphate analogues
Kim et al.	2002	Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors
Nomura et al.	1999	Nucleosides and nucleotides. 185. Synthesis and biological activities of 4 ‘α-C-Branched-Chain sugar pyrimidine nucleosides
Borchardt et al.	1974	Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 1. Modification of the amino acid portion of S-adenosylhomocysteine
JP6012605B2 (ja)	2016-10-25	置換されたヌクレオチドアナログ
Miller et al.	1973	Synthesis and biological activity of some 2'derivatives of adenosine 3', 5'-cyclic phosphate
FI2604620T4 (fi)	2024-09-11	Modifioituja fluorinoituja nukleosidianalogeja
MX167702B (es)	1993-04-06	Composicion farmaceutica anti-retroviral de 3'azid-2',3'-dideoxiuridina y metodo para elaborarla
BR0011521A (pt)	2002-03-26	Composto nucleósidos de purina de 4' -c-etinila
US20100062995A1 (en)	2010-03-11	Transition state structure of human 5'methylthioadenosine phosphorylase
ATE196912T1 (de)	2000-10-15	Propargylethoxyamino nucleotide
CA2476282A1 (en)	2003-08-21	Dosing regimen for gemcitabine hcv therapy
Gillerman et al.	2010	An improved one-pot synthesis of nucleoside 5′-triphosphate analogues
ATE432284T1 (de)	2009-06-15	Einen starren linker enthaltende nukleotide
KR970701198A (ko)	1997-03-17	3'-치환 뉴클레오시드 유도체(3'-substituted nucleoside derivative)
Sun et al.	2008	One-pot synthesis of nucleoside 5′-triphosphates from nucleoside 5′-H-phosphonates
Zatorski et al.	1995	Potent inhibitors of human inosine monophosphate dehydrogenase type II. fluorine-substituted analogs of thiazole-4-carboxamide adenine dinucleotide
van Wijk et al.	1991	Lipid conjugates of antiretroviral agents: release of antiretroviral nucleoside monophosphates by a nucleoside diphosphate diglyceride hydrolase activity from rat liver mitochondria
IL142983A0 (en)	2002-04-21	Nucleosides with anti-hepatisis b virus activity
Périgaud et al.	1999	The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis (S-acyl-2-thioethyl) phosphotriester derivatives of acyclovir
ES2164869T3 (es)	2002-03-01	Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos.
BR0016162A (pt)	2002-08-13	Composições e métodos para l-nucleosìdeos, lnucleotìdeos e seus análogos